The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Regeneron Pharmaceuticals, Inc’s stock clocked out at $522.68, down -1.24% from its previous closing price of $529.24. In other words, the price has decreased by -$1.24 from its previous closing price. On the day, 1.32 million shares were traded.
Ratios:
To gain a deeper understanding of REGN’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.76 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 18.19. For the most recent quarter (mrq), Quick Ratio is recorded 4.03 and its Current Ratio is at 4.93. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.
On May 30, 2025, RBC Capital Mkts Downgraded its rating to Sector Perform which previously was Outperform but kept the price unchanged to $662.
Citigroup Upgraded its Neutral to Buy on May 14, 2025, while the target price for the stock was maintained at $700.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 01 ’24 when McCourt Marion sold 1,000 shares for $844.61 per share. The transaction valued at 844,610 led to the insider holds 12,931 shares of the business.
MARION E MCCOURT bought 1,000 shares of REGN for $844,610 on Nov 01 ’24. On Oct 01 ’24, another insider, RYAN ARTHUR F, who serves as the Director of the company, sold 100 shares for $1048.78 each. As a result, the insider received 104,878 and left with 17,582 shares of the company.
Valuation Measures:
As of this moment, Regeneron’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.30, and their Forward P/E ratio for the next fiscal year is 13.20. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 9.78. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.01 while its Price-to-Book (P/B) ratio in mrq is 1.92.
Stock Price History:
Over the past 52 weeks, REGN has reached a high of $1211.20, while it has fallen to a 52-week low of $476.49. The 50-Day Moving Average of the stock is -6.99%, while the 200-Day Moving Average is calculated to be -30.73%.
Shares Statistics:
A total of 106.40M shares are outstanding, with a floating share count of 104.06M. Insiders hold about 3.61% of the company’s shares, while institutions hold 87.17% stake in the company.
